نتائج البحث - "Glucagon-Like Peptide-1 Receptor"

1

دورية أكاديمية

Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta‐regression.

المؤلفون: Rivera, Frederick Berro¹ (AUTHOR), Lumbang, Grace Nooriza O.² (AUTHOR), Gaid, Danielle Rose Magno² (AUTHOR), Cruz, Linnaeus Louisse A.³ (AUTHOR), Magalong, John Vincent³ (AUTHOR), Bantayan, Nathan Ross B.³ (AUTHOR), Lara‐Breitinger, Kyla M.⁴ (AUTHOR), Gulati, Martha⁵ (AUTHOR), Bakris, George⁶ (AUTHOR) gbakris@gmail.com

المصدر: Diabetes, Obesity & Metabolism. Jun2024, Vol. 26 Issue 6, p2209-2228. 20p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *BLOOD pressure, *SYSTOLIC blood pressure, *DIABETES, *RANDOM effects model, *PEPTIDE receptors

2

دورية أكاديمية

Comparison of clinical efficacy and safety of weekly glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel‐group, multicentre, open‐label trial (COMING study)

المؤلفون: Kimura, Tomohiko^1,2 (AUTHOR) tomohiko@med.kawasaki-m.ac.jp, Katakura, Yukino¹ (AUTHOR), Shimoda, Masashi¹ (AUTHOR), Kawasaki, Fumiko³ (AUTHOR), Yamabe, Mizuho⁴ (AUTHOR), Tatsumi, Fuminori¹ (AUTHOR), Matsuki, Michihiro⁵ (AUTHOR), Iwamoto, Yuichiro¹ (AUTHOR), Anno, Takatoshi³ (AUTHOR), Fushimi, Yoshiro¹ (AUTHOR), Kamei, Shinji⁶ (AUTHOR), Kimura, Yukiko^2,3 (AUTHOR), Nakanishi, Shuhei¹ (AUTHOR), Mune, Tomoatsu¹ (AUTHOR), Kaku, Kohei³ (AUTHOR), Kaneto, Hideaki¹ (AUTHOR)

المصدر: Diabetes, Obesity & Metabolism. Dec2023, Vol. 25 Issue 12, p3632-3647. 16p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *TYPE 2 diabetes, *JAPANESE people, *SEMAGLUTIDE, *GLUCAGON receptors, *PEPTIDE receptors

3

دورية أكاديمية

Efficacy and safety of semaglutide 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trials.

المؤلفون: Rubino, Domenica, Angelene, Hanna, Fabricatore, Anthony, Ard, Jamy

المصدر: Obesity (19307381); Jul2024, Vol. 32 Issue 7, p1268-1280, 13p

مصطلحات موضوعية: RACE, GLUCAGON-like peptide-1 receptor, SEMAGLUTIDE, ETHNICITY, CLINICAL trials

4

دورية أكاديمية

Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts.

المصدر: Diabetes, Obesity & Metabolism; Jun2024, Vol. 26 Issue 6, p2390-2400, 11p

مصطلحات موضوعية: TYPE 2 diabetes, SEMAGLUTIDE, GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, BODY mass index

5

دورية أكاديمية

Effectiveness and safety of once‐weekly subcutaneous semaglutide versus other glucose‐lowering agents in real‐world patients with type 2 diabetes: A retrospective, observational post‐marketing study.

المؤلفون: Shi, Chenyang, Tan, Yijiong, Hu, Shanshan, Qin, Yingyi, Tang, Yuanjun, Wang, Yufan, Fan, Guorong

المصدر: Diabetes, Obesity & Metabolism; Jun2024, Vol. 26 Issue 6, p2513-2516, 4p

مصطلحات موضوعية: TYPE 2 diabetes, SEMAGLUTIDE, ASPARTATE aminotransferase, WEIGHT loss, GLUCAGON-like peptide-1 receptor, SCIENTIFIC observation

6

دورية أكاديمية

Efficacy and safety of semaglutide in patients with heart failure with preserved ejection fraction and obesity.

المؤلفون: Rehman, Ayesha, Saidullah, Shahab, Asad, Muhammad, Gondal, Umer R., Ashraf, Amna, Khan, Muhammad F., Akhtar, Waheed, Mehmoodi, Amin, Malik, Jahanzeb

المصدر: Clinical Cardiology; May2024, Vol. 47 Issue 5, p1-8, 8p

مصطلحات موضوعية: HEART failure patients, VENTRICULAR ejection fraction, GLUCAGON-like peptide-1 receptor, PATIENT safety, WEIGHT loss, INTERMITTENT claudication

النص الكامل

7

دورية أكاديمية

Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial.

المؤلفون: Vernstrøm, Liv, Gullaksen, Søren, Sørensen, Steffen S., Funck, Kristian L., Laugesen, Esben, Poulsen, Per L.

المصدر: Diabetes, Obesity & Metabolism; May2024, Vol. 26 Issue 5, p1624-1635, 12p

مصطلحات موضوعية: PHOTOPLETHYSMOGRAPHY, SODIUM-glucose cotransporter 2 inhibitors, CONTINUOUS glucose monitoring, SODIUM-glucose cotransporters, BLOOD pressure, SEMAGLUTIDE, PULSE wave analysis, GLUCAGON-like peptide-1 receptor

8

دورية أكاديمية

The cardioprotective effect of human glucagon‐like peptide‐1 receptor agonist (semaglutide) on cisplatin‐induced cardiotoxicity in rats: Targeting mitochondrial functions, dynamics, biogenesis, and redox status pathways.

المؤلفون: Atef, Marwa Mohamed¹ (AUTHOR) marwa_atef_khald@yahoo.com, Hafez, Yasser Mostafa² (AUTHOR), El‐Deeb, Omnia Safwat¹ (AUTHOR), Basha, Eman H.³ (AUTHOR), Ismail, Radwa⁴ (AUTHOR), Alshenawy, Hanan⁵ (AUTHOR), El‐Esawy, Rasha Osama⁶ (AUTHOR), Eltokhy, Amira Kamel¹ (AUTHOR)

المصدر: Cell Biochemistry & Function. Jun2023, Vol. 41 Issue 4, p450-460. 11p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *CARDIOTOXICITY, *MEMBRANE potential, *SEMAGLUTIDE

9

دورية أكاديمية

Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes.

المؤلفون: Aroda, Vanita R.¹ (AUTHOR) varoda@bwh.harvard.edu, Erhan, Umut² (AUTHOR), Jelnes, Peter² (AUTHOR), Meier, Juris J.³ (AUTHOR), Abildlund, Morten Tind² (AUTHOR), Pratley, Richard⁴ (AUTHOR), Vilsbøll, Tina⁵ (AUTHOR), Husain, Mansoor⁶ (AUTHOR)

المصدر: Diabetes, Obesity & Metabolism. May2023, Vol. 25 Issue 5, p1385-1397. 13p.

مصطلحات موضوعية: *SEMAGLUTIDE, *GLUCAGON-like peptide-1 receptor, *MAJOR adverse cardiovascular events, *ARRHYTHMIA, *GLUCAGON-like peptide-1 agonists, *CLINICAL trials

10

دورية أكاديمية

Therapeutic inertia related to the injectable glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care.

المؤلفون: von Arx, Lill‐Brith¹ (AUTHOR) von_arx_lill_brith_wium@lilly.com, Rachman, Jonathan² (AUTHOR), Webb, Joanne² (AUTHOR), Casey, Caroline³ (AUTHOR), Patel, Amisha³ (AUTHOR), Diomatari, Christina³ (AUTHOR), Wood, Robert³ (AUTHOR), Idris, Iskandar⁴ (AUTHOR)

المصدر: Diabetes, Obesity & Metabolism. May2023, Vol. 25 Issue 5, p1331-1340. 10p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *TYPE 2 diabetes, *SEMAGLUTIDE, *PRIMARY care, *GLUCAGON receptors, *PEPTIDE receptors

مصطلحات جغرافية: UNITED Kingdom

تنقيح النتائج